Literature DB >> 14708924

Hemophilia during pregnancy.

Ran D Goldman1, Victor Blanchette, Gideon Koren.   

Abstract

QUESTION: A patient in my clinic, who is 10 weeks into her first pregnancy and is a known carrier of hemophilia B, is considering the advantages and disadvantages of antenatal tests and is especially worried about a vaginal delivery thatmight cause bleeding. How should I manage her pregnancy? ANSWER: Many female carriers of hemophilia were found to have lower-than-expected levels of plasma factors, which are thought to be due to X chromosome inactivation. Chorionic villous sampling is the preferred test to determine the sex of the fetus and whether a male infant is affected with hemophilia. Vaginal delivery is not contraindicated and has been proven during the last two decades to be as safe as cesarean section. Vacuum extraction should be avoided to minimize risk of intracranial hemolysis and severe cephalhematoma.

Entities:  

Mesh:

Year:  2003        PMID: 14708924      PMCID: PMC2214172     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

Review 1.  Management of pregnancy in carriers of haemophilia.

Authors:  P L Giangrande
Journal:  Haemophilia       Date:  1998-11       Impact factor: 4.287

2.  Reproductive choices of women in families with haemophilia.

Authors:  R A Kadir; C A Sabin; E Goldman; D Pollard; D L Economides; C A Lee
Journal:  Haemophilia       Date:  2000-01       Impact factor: 4.287

3.  Sex chromatin and gene action in the mammalian X-chromosome.

Authors:  M F LYON
Journal:  Am J Hum Genet       Date:  1962-06       Impact factor: 11.025

4.  Intracranial hemorrhage in newborn and young infants with hemophilia.

Authors:  G Yoffe; G R Buchanan
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

5.  Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council.

Authors:  R Kulkarni; J M Lusher; R C Henry; D J Kallen
Journal:  Haemophilia       Date:  1999-11       Impact factor: 4.287

6.  Central nervous system bleeding in hemophiliacs.

Authors:  M E Eyster; F M Gill; P M Blatt; M W Hilgartner; J O Ballard; T R Kinney
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

7.  Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers.

Authors:  I Varekamp; T P Suurmeijer; A H Bröcker-Vriends; H van Dijck; C Smit; F R Rosendaal; E Briët
Journal:  Am J Med Genet       Date:  1990-09

8.  The obstetric experience of carriers of haemophilia.

Authors:  R A Kadir; D L Economides; J Braithwaite; E Goldman; C A Lee
Journal:  Br J Obstet Gynaecol       Date:  1997-07

9.  Obstetric care of the affected carrier of hemophilia B.

Authors:  J W Seeds; R C Cefalo; D T Miller; P M Blatt
Journal:  Obstet Gynecol       Date:  1983-09       Impact factor: 7.661

10.  Normal vaginal delivery is to be recommended for haemophilia carrier gravidae.

Authors:  R Ljung; A C Lindgren; P Petrini; L Tengborn
Journal:  Acta Paediatr       Date:  1994-06       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.